Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 35INS

Blood

Volumn 115, Issue 18, 2010, Pages 3852-

  Mahadeo, Kris M ^a   Cole, Peter D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CYTARABINE; DASATINIB; IMATINIB; OMACETAXINE; UNCLASSIFIED DRUG; HARRINGTONINE DERIVATIVE; HOMOHARRINGTONINE;

ADULT; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL EVALUATION; CYTOGENETICS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXON; FEMALE; GENE INSERTION; HEADACHE; HUMAN; LETTER; LEUKOCYTE COUNT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALVAGE THERAPY; TREATMENT OUTCOME; GENETICS; METABOLISM; PATHOLOGY;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; FUSION PROTEINS, BCR-ABL; HARRINGTONINES; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952572919     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-02-269233     Document Type: Letter

References (5)

1. Lee T-S, Ma W, Zhang X, et al. BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations. Mol Cancer Ther. 2008;7(12):3834-3841.
2. O'Hare T, Shakespeare WC, Zhu X, et al. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell. 2009;16(5):401-412.
3. Bruey J, Kantarjian H, Ma W, et al. Alternatively spliced truncated BCR-ABL1 protein in CML patients with resistance to kinase inhibitors. J Clin Oncol. 2009;27:15S.
4. Kantarjian HM, Talpaz M, Santini V, et al. Homoharringtonine: history, current research, and future direction. Cancer. 2001;92(6):1591-1605.
5. Jin Y, Lu Z, Cao K, et al. The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation. Mol Cancer Ther. 2010;9(1):211-223.